Mirati Therapeutics
MRTX
$58.70
Share price
0.00%
Change (1 day)
29.75%
Change (1 year)
Categories
Operating Margin for Mirati Therapeutics (MRTX)
Operating Margin as of May 2024 (TTM): -5,953.35%
According to Mirati Therapeutics's latest financial reports and stock price the company's current Operating Margin is -5,953.35%. At the end of 2022 the company had an Operating Margin of -5,953.35%.
Operating Margin history for Mirati Therapeutics from 2005 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -5,953.35% | 641.92% |
| 2021 | -802.43% | -69.96% |
| 2020 | -2,671.57% | -58.22% |
| 2019 | -6,394.48% | 739.84% |
| 2018 | -761.40% | |
| 2012 | -1,010,750.00% | 312768.05% |
| 2011 | -323.06% | -47.45% |
| 2010 | -614.78% | -20.85% |
| 2009 | -776.69% | 2412.44% |
| 2008 | -30.91% | -78.24% |
| 2007 | -142.07% | 1569.78% |
| 2006 | -8.51% | -96.28% |
| 2005 | -228.63% | 93.2% |
| 2004 | -118.34% | 121.36% |
| 2003 | -53.46% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 TravelCenters of America TA | 1.71% | -100.03% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | -234,760.00% | 3,843.33% | Bahamas |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.